Galera Therapeutics Inc.: Submission of Matters to a Vote of Security Holders (Form 8-K) - MoneyController (ID 127704)
Galera Therapeutics Inc. | BioWorld
Robert Beardsley - Co-Founder, Executive Chair & Chief Operating Officer - Galera Therapeutics, Inc. | LinkedIn
Galera Therapeutics Inc. (@GaleraTx) / Twitter
Galera Therapeutics | NEA | New Enterprise Associates
Galera Therapeutics (GRTX) Investor Presentation - Slideshow (NASDAQ:GRTX) | Seeking Alpha
Galera Therapeutics - SEC Filing
Galera Therapeutics, Inc. | LinkedIn
CFO of the Year Awards 2020: Chris Degnan, Galera Therapeutics Inc. - Philadelphia Business Journal
Galera Therapeutics Inc (GRTX) has gained 15.88% in a Week, Should You Buy?
EX-99.1
Galera Therapeutics - Crunchbase Company Profile & Funding
Galera Therapeutics Inc. (@GaleraTx) / Twitter
EX-99.1
Galera Therapeutics Inc. (@GaleraTx) / Twitter
Daniel Burnip - Director, IT - Galera Therapeutics, Inc. | LinkedIn
Galera Therapeutics Inc. (@GaleraTx) / Twitter
Form of Certificate of Common Stock | Galera Therapeutics, Inc. | Business Contracts | Justia
Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants
GALERA THERAPEUTICS, INC. : Technical Analysis Chart | GRTX | US36338D1081 | MarketScreener
GALERA THERAPEUTICS, INC. : GRTX Stock Price | US36338D1081 | MarketScreener
GALERA THERAPEUTICS INC. (GRTX) option trades
Galera Therapeutics - Graphic Beans
